BridgeBio Oncology Therapeutics, Inc. Common Stock (BBOT)

$7.44 +5.08%

EARNINGS ANALYTICS

BridgeBio Oncology Therapeutics, Inc. Common Stock (BBOT) has only 2 recorded earnings events on file, so its post-earnings track record is limited. Its biggest recorded post-earnings gain was +5.72% (Mar 05, 2026) and its biggest decline was -4.81% (Nov 12, 2025).

Earnings Price Reaction

Scroll to zoom, drag to pan — click earnings dots for details

Beat Miss

Earnings Impact

Total Earnings

Avg Abs. Movement

±5.26%

Positive %

50.0%

Negative %

50.0%

Historical Earnings Statistics

Date	Timing	Open	High	Close	Volume	Movement %	SEC Filing
Mar 05, 2026	☽ POST	$10.01	$10.15	$9.96	10,385	+5.72%	open_in_new
Nov 12, 2025	☽ POST	$12.82	$12.82	$12.69	1,329	-4.81%	open_in_new

event

Earnings Count

Total earnings in dataset

trending_up

Avg Abs. Movement

±5.26%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

SEC Filing Types

description 424B3

1 chevron_right

Recent SEC Filings

1 most recent

Form	Date Filed	View on EDGAR
424B3	20260513	open_in_new SEC.gov

Frequently asked about BBOT earnings

How much does BBOT stock move after earnings? expand_more

Over 2 reports, BBOT has moved an average of ±5.26% the session after earnings, closing higher 50.0% of the time.

What was BBOT's biggest post-earnings move? expand_more

BBOT's largest post-earnings gain on record was +5.72% on Mar 05, 2026, and its largest decline was -4.81% on Nov 12, 2025.

Where can I find BridgeBio Oncology Therapeutics, Inc. Common Stock's SEC filings? expand_more

All of BridgeBio Oncology Therapeutics, Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.